» Articles » PMID: 35177471

Molecular Basis of Force-pCa Relation in Cardiomyopathy Mice: Role of the Super-relaxed State of Myosin

Overview
Specialty Science
Date 2022 Feb 18
PMID 35177471
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we investigated the role of the super-relaxed (SRX) state of myosin in the structure-function relationship of sarcomeres in the hearts of mouse models of cardiomyopathy-bearing mutations in the human ventricular regulatory light chain (RLC, gene). Skinned papillary muscles from hypertrophic (HCM-D166V) and dilated (DCM-D94A) cardiomyopathy models were subjected to small-angle X-ray diffraction simultaneously with isometric force measurements to obtain the interfilament lattice spacing and equatorial intensity ratios (I/I) together with the force-pCa relationship over a full range of [Ca] and at a sarcomere length of 2.1 μm. In parallel, we studied the effect of mutations on the ATP-dependent myosin energetic states. Compared with wild-type (WT) and DCM-D94A mice, HCM-D166V significantly increased the Ca sensitivity of force and left shifted the I/I-pCa relationship, indicating an apparent movement of HCM-D166V cross-bridges closer to actin-containing thin filaments, thereby allowing for their premature Ca activation. The HCM-D166V model also disrupted the SRX state and promoted an SRX-to-DRX (super-relaxed to disordered relaxed) transition that correlated with an HCM-linked phenotype of hypercontractility. While this dysregulation of SRX ↔ DRX equilibrium was consistent with repositioning of myosin motors closer to the thin filaments and with increased force-pCa dependence for HCM-D166V, the DCM-D94A model favored the energy-conserving SRX state, but the structure/function-pCa data were similar to WT. Our results suggest that the mutation-induced redistribution of myosin energetic states is one of the key mechanisms contributing to the development of complex clinical phenotypes associated with human HCM-D166V and DCM-D94A mutations.

Citing Articles

Dual effect of N-terminal deletion of cardiac myosin essential light chain in mitigating cardiomyopathy.

Sitbon Y, Kazmierczak K, Liang J, Kloehn A, Vinod J, Kanashiro-Takeuchi R iScience. 2024; 27(8):110591.

PMID: 39211545 PMC: 11357882. DOI: 10.1016/j.isci.2024.110591.


Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

Spudich J, Nandwani N, Robert-Paganin J, Houdusse A, Ruppel K EMBO J. 2024; 43(19):4139-4155.

PMID: 39192034 PMC: 11445530. DOI: 10.1038/s44318-024-00199-x.


Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patients.

Van Den Berg M, Shi Z, Claassen W, Hooijman P, Lewis C, Andersen J Sci Transl Med. 2024; 16(758):eadg3894.

PMID: 39083588 PMC: 11586073. DOI: 10.1126/scitranslmed.adg3894.


Mechanisms and Risk Factors for Premature Ventricular Contraction Induced Cardiomyopathy.

Shen X, Zhu X, Zuo L, Liu X, Qin M Rev Cardiovasc Med. 2024; 24(12):353.

PMID: 39077080 PMC: 11272849. DOI: 10.31083/j.rcm2412353.


Assessing Cardiac Contractility From Single Molecules to Whole Hearts.

Garg A, Lavine K, Greenberg M JACC Basic Transl Sci. 2024; 9(3):414-439.

PMID: 38559627 PMC: 10978360. DOI: 10.1016/j.jacbts.2023.07.013.


References
1.
Huke S, Knollmann B . Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility. J Mol Cell Cardiol. 2010; 48(5):824-33. PMC: 2854218. DOI: 10.1016/j.yjmcc.2010.01.011. View

2.
McNamara J, Li A, Dos Remedios C, Cooke R . The role of super-relaxed myosin in skeletal and cardiac muscle. Biophys Rev. 2017; 7(1):5-14. PMC: 5425749. DOI: 10.1007/s12551-014-0151-5. View

3.
Stewart M, Franks-Skiba K, Chen S, Cooke R . Myosin ATP turnover rate is a mechanism involved in thermogenesis in resting skeletal muscle fibers. Proc Natl Acad Sci U S A. 2009; 107(1):430-5. PMC: 2806748. DOI: 10.1073/pnas.0909468107. View

4.
Spudich J . Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Pflugers Arch. 2019; 471(5):701-717. PMC: 6475635. DOI: 10.1007/s00424-019-02259-2. View

5.
Toepfer C, Garfinkel A, Venturini G, Wakimoto H, Repetti G, Alamo L . Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy. Circulation. 2020; 141(10):828-842. PMC: 7077965. DOI: 10.1161/CIRCULATIONAHA.119.042339. View